NCT01093222 2015-06-30Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or CholangiocarcinomaNational Cancer Institute (NCI)Phase 2 Completed40 enrolled 16 charts